Basecke Jorg, Whelan Jarrett T, Griesinger Frank, Bertrand Fred E
Division of Haematology and Oncology, University of Goettingen, Goettingen, Germany.
Br J Haematol. 2006 Nov;135(4):438-49. doi: 10.1111/j.1365-2141.2006.06301.x. Epub 2006 Sep 11.
Mixed lineage leukaemia gene-partial tandem duplications (MLL-PTD) characterise acute myeloid leukaemia (AML) with trisomy 11 and AML with a normal karyotype. MLL-PTD confer a worse prognosis with shortened overall and event free survival in childhood and adult AML. In spite of these clinical observations, the leukaemogenic mechanism has, so far, not been determined. This review summarises clinical studies on MLL-PTD positive AML and recent experimental findings on the putative leukaemogenic role of MLL-PTD.
混合谱系白血病基因部分串联重复(MLL-PTD)是伴有11号染色体三体的急性髓系白血病(AML)和核型正常的AML的特征。MLL-PTD预示着儿童和成人AML的预后较差,总生存期和无事件生存期缩短。尽管有这些临床观察结果,但迄今为止,白血病发生机制尚未确定。本综述总结了关于MLL-PTD阳性AML的临床研究以及关于MLL-PTD假定致白血病作用的最新实验发现。